ENSC
Ensysce Biosciences·NASDAQ
--
--(--)
--
--(--)
ENSC fundamentals
Ensysce Biosciences (ENSC) released its earnings on Aug 13, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.79 (YoY +76.06%), beat estimates.
Revenue / YoY
--
--
EPS / YoY
-0.79
+76.06%
Report date
Aug 13, 2025
EPS
Actual | -10.8 | -127.8 | -81 | -10.8 | -43.2 | -923.4 | -31.2 | -14.7 | -13.05 | -16.95 | -8.25 | -3.3 | 1.05 | -2.9 | -1.39 | -0.79 |
Forecast | -127.8 | 16.2 | -28.8 | -30.6 | -28.8 | -76.15 | -27.8 | -15.85 | -13.05 | -13.5 | -5.85 | 1.05 | -2.735 | -3.015 | -1.015 | |
Surprise | 0.00% | 0.00% | -600.00% | +62.50% | -41.18% | -3106.25% | +59.03% | +47.12% | +17.67% | -29.89% | +38.89% | +43.59% | 0.00% | -6.03% | +53.90% | +22.17% |
Revenue
Actual | 400.00K | 1.20M | 1.00M | 600.00K | 200.00K | 300.00K | 800.00K | 495.00K | 420.00K | 505.00K | 305.00K | 200.00K | 3.41M | 1.30M | 1.31M | -- |
Forecast | -- | 1.20M | 800.00K | 1.20M | 1.00M | 1.00M | 950.00K | 760.00K | 593.33K | 395.00K | 400.00K | 300.00K | 3.40M | 245.00K | 0 | 650.00K |
Surprise | 0.00% | 0.00% | +25.00% | -50.00% | -80.00% | -70.00% | -15.79% | -34.87% | -29.21% | +27.85% | -23.75% | -33.33% | +0.29% | +430.61% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Ensysce Biosciences's revenue and profit?What is Ensysce Biosciences's gross profit margin?What is the revenue and EPS growth rate for Ensysce Biosciences year over year?What is Ensysce Biosciences's latest dividend and current dividend yield?What were the key takeaways from Ensysce Biosciences's earnings call?What guidance did Ensysce Biosciences's management provide for the next earnings period?Did Ensysce Biosciences beat or miss consensus estimates last quarter?What does Ensysce Biosciences do and what are its main business segments?
